14th European Congress of Clinical Microbiology and Infectious ...
14th European Congress of Clinical Microbiology and Infectious ...
14th European Congress of Clinical Microbiology and Infectious ...
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Poster Sessions Sunday, May 2, 2004<br />
P670 Comparison <strong>of</strong> two commercial assays for the<br />
quantification <strong>of</strong> HIV-RNA<br />
L. Valdés, S. García-Bujalance, M.P. Romero,<br />
C. Ladrón de Guevara (Madrid, E)<br />
P671 Evaluation <strong>of</strong> a simplified protocol <strong>of</strong> the<br />
Versant bDNA HIV 3.0 for HIV-1 viral load<br />
quantitation<br />
F. Salvá, M. Rotger, E. Ruiz, H. Machado,<br />
M. Gaya, C. Alonso, J.L. Perez<br />
(Palma de Mallorca, E)<br />
P672 HIV-1 viral load by NucliSens EasyQ HIV-1<br />
v1.1 in combination with the NucliSens mini<br />
MAG instrument<br />
P. van Deursen, T. Oosterlaken, T. Cuypers,<br />
A. Verhoeven, P. de Bie, R. Bosch, I. Berghuis,<br />
M. Jacobs, P. van de Wiel (Boxtel, Amsterdam, NL)<br />
P673 Comparative study <strong>of</strong> two techniques to<br />
measure HIV-1 viral load in a French<br />
commercial laboratory<br />
G. Kreplak, R. Legouge (Paris, F)<br />
P674 Evolution <strong>of</strong> hypervariable region 1 <strong>of</strong><br />
hepatitis C virus in HIV- HCV co-infected<br />
patients after treatment with highly active<br />
antiretroviral therapy<br />
M. Solmone, E. Lalle, E. Girardi, G. Antonucci,<br />
P. Pizzaferri, G. Migliorino, M. De Marco,<br />
M.R. Capobianchi, A. D'Arminio Monforte –<br />
I.Co.N.A. Study Group<br />
13:00–14:00<br />
Antimicrobial resistance mechanisms – I<br />
P675 Development <strong>of</strong> endogenous resistance by<br />
staphylococci to BAL9141 <strong>and</strong> comparators<br />
S. Heller, E. Marrer, M.G.P. Page, S. Shapiro,<br />
L. Thenoz (Basle, CH)<br />
P676 Emergence <strong>and</strong> dissemination <strong>of</strong><br />
glycopeptide- <strong>and</strong> high-level quinupristindalfopristin<br />
resistant Enterococcus faecium<br />
clones in various wards <strong>of</strong> a tertiary hospital<br />
S. Pournaras, M. Kanellopoulou, A. Ikonomidis,<br />
E. Papafrangas, A.N. Maniatis (Larissa, Athens, GR)<br />
P677 Evidence <strong>of</strong> reserpine-affected mechanism<br />
<strong>of</strong> resistance to tetracycline in Neisseria<br />
gonorrhoeae clinical isolates<br />
J. Ruiz, A. Ribera, A. Jurado, F. Marco,<br />
M.T. Jiménez de Anta, J. Vila (Barcelona, E)<br />
P678 Distribution <strong>of</strong> ermA, ermC, msrA <strong>and</strong> linA<br />
genes in methicillin-resistant staphylococci<br />
in the Czech Republic<br />
G. Novotna, J. Janata, J. Spizek (Prague, CZ)<br />
page 78 Final Programme<br />
P679 Fluoroquinolone-selected resistance among<br />
Pseudomonas aeruginosa: impact on<br />
susceptibility to imipenem, ertapenem, <strong>and</strong><br />
meropenem<br />
P. Lister, A. Hossain, J.A. Black, E. Smith-Mol<strong>and</strong>,<br />
N.D. Hanson (Omaha, USA)<br />
P680 High prevalence <strong>of</strong> macrolide resistance<br />
in Streptococcus mitis from neutropenic<br />
patients<br />
W. Achour, O. Guenni, B. Malbruny, A. Canu,<br />
R. Leclercq, A. Ben Hassen (Tunis, TN)<br />
P681 Frequency <strong>and</strong> stability <strong>of</strong> mutants selected<br />
with fluoroquinolones from Klebsiella<br />
pneumoniae containing the plasmid-mediated<br />
resistance determinant QNR<br />
J.M. Rodriguez-Martinez, A. Pascual, I. Garcia,<br />
E. Jiménez-Mejias, J. Pachón, L. Martínez-<br />
Martínez (Seville, E)<br />
P682 Resistance mechanisms <strong>of</strong> fluoroquinoloneresistant<br />
clinical isolates <strong>of</strong> Streptococcus<br />
pneumoniae collected in Belgium, 1999–2003<br />
S. De Craeye, R. Vanho<strong>of</strong>, N. Celio, S. Damée,<br />
E. Vanbossuyt, J. Content (Brussels, B)<br />
P683 Inducible metronidazole resistance in nimpositive<br />
clinical Bacteroides fragilis group<br />
strains<br />
M. Hedberg, H. Fang, C. Edlund (Stockholm, S)<br />
P684 Diversity <strong>of</strong> the mechanisms involved in<br />
imipenem resistance in Acinetobacter<br />
baumannii<br />
S. Bourdon, M.L. Joly-Guillou (Angers, F)<br />
P685 Cross-resistance between voriconazole <strong>and</strong><br />
fluconazole due to the expression <strong>of</strong> efflux<br />
pumps<br />
S. Costa-de-Oliveira, C. Pina-Vaz, A. Gonçalves<br />
Rodrigues (Porto, P)<br />
P686 Substrate inhibition <strong>of</strong> the Pseudomonas<br />
aeruginosa metallo-beta-lactamase, SPM-1,<br />
in acidic <strong>and</strong> alkaline conditions<br />
T.A. Murphy, J. Spencer, R.N. Jones, T.R. Walsh<br />
(Bristol, UK; North Liberty, USA)<br />
P687 Class 1 <strong>and</strong> class 2 integrons among ESBL<br />
<strong>and</strong> non-ESBL Escherichia coli isolates<br />
recovered from nosocomial <strong>and</strong> community<br />
environments<br />
E. Machado, R. Cantón, J.C. Galán, A. Rollán,<br />
L. Peixe, F. Baquero, T.M. Coque<br />
(Madrid, Porto, E)<br />
P688 Induction <strong>of</strong> the Acinetobacter baumannii<br />
RND efflux pump AdeB with cipr<strong>of</strong>loxacin <strong>and</strong><br />
gentamicin<br />
H. Seifert (Cologne, D)
Change language